Concepts (175)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Orthoreovirus | 1 | 2019 | 5 | 0.79 | Why? |
| Disease Reservoirs | 7 | 2021 | 1672 | 0.77 | Why? |
| Reoviridae Infections | 1 | 2019 | 31 | 0.76 | Why? |
| Chiroptera | 9 | 2021 | 3530 | 0.75 | Why? |
| Zoonoses | 5 | 2020 | 3034 | 0.66 | Why? |
| Monkey Diseases | 1 | 2019 | 190 | 0.66 | Why? |
| Macaca fascicularis | 2 | 2019 | 1009 | 0.57 | Why? |
| Dengue Virus | 1 | 2018 | 910 | 0.43 | Why? |
| Whole Genome Sequencing | 2 | 2021 | 3239 | 0.42 | Why? |
| Genome, Viral | 10 | 2021 | 13157 | 0.40 | Why? |
| Zika Virus | 2 | 2018 | 1924 | 0.37 | Why? |
| Zika Virus Infection | 2 | 2018 | 1920 | 0.34 | Why? |
| Communicable Diseases, Emerging | 2 | 2020 | 2523 | 0.34 | Why? |
| Dengue | 1 | 2018 | 1565 | 0.30 | Why? |
| Singapore | 8 | 2021 | 3641 | 0.27 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.27 | Why? |
| SARS Virus | 3 | 2020 | 13021 | 0.24 | Why? |
| Streptavidin | 1 | 2021 | 27 | 0.22 | Why? |
| Virus Diseases | 1 | 2019 | 3779 | 0.22 | Why? |
| Severe Acute Respiratory Syndrome | 3 | 2020 | 12361 | 0.21 | Why? |
| Camelus | 2 | 2019 | 1425 | 0.20 | Why? |
| Molecular Probes | 1 | 2021 | 106 | 0.20 | Why? |
| Hendra Virus | 1 | 2019 | 31 | 0.20 | Why? |
| Antibodies, Viral | 9 | 2021 | 51949 | 0.18 | Why? |
| DNA, Complementary | 1 | 2021 | 568 | 0.18 | Why? |
| Complement C1q | 1 | 2018 | 31 | 0.18 | Why? |
| Filoviridae | 1 | 2019 | 70 | 0.18 | Why? |
| Gene Deletion | 1 | 2020 | 430 | 0.18 | Why? |
| Coinfection | 1 | 2018 | 6820 | 0.18 | Why? |
| Haplorhini | 1 | 2018 | 307 | 0.17 | Why? |
| Open Reading Frames | 2 | 2020 | 1898 | 0.16 | Why? |
| Coronavirus | 6 | 2020 | 18339 | 0.15 | Why? |
| Conjunctivitis, Viral | 1 | 2020 | 301 | 0.15 | Why? |
| Animal Diseases | 1 | 2018 | 182 | 0.15 | Why? |
| Animals | 15 | 2021 | 78931 | 0.14 | Why? |
| Computational Biology | 2 | 2021 | 4514 | 0.14 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2019 | 572 | 0.14 | Why? |
| RNA | 1 | 2021 | 1278 | 0.13 | Why? |
| NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2019 | 581 | 0.13 | Why? |
| Alphacoronavirus | 1 | 2018 | 392 | 0.13 | Why? |
| Nasal Mucosa | 1 | 2020 | 1218 | 0.12 | Why? |
| Eye Infections, Viral | 1 | 2020 | 517 | 0.12 | Why? |
| Coronavirus Infections | 14 | 2020 | 253789 | 0.11 | Why? |
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3633 | 0.11 | Why? |
| Cross Reactions | 2 | 2020 | 4374 | 0.10 | Why? |
| Swine | 1 | 2018 | 3352 | 0.09 | Why? |
| Polymerase Chain Reaction | 2 | 2021 | 6740 | 0.09 | Why? |
| Neutralization Tests | 2 | 2020 | 6698 | 0.09 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 3 | 2019 | 8843 | 0.09 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.09 | Why? |
| Pregnancy Outcome | 1 | 2020 | 3803 | 0.08 | Why? |
| Betacoronavirus | 11 | 2020 | 204454 | 0.08 | Why? |
| Autoantibodies | 1 | 2018 | 2094 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.08 | Why? |
| RNA, Viral | 4 | 2021 | 32276 | 0.08 | Why? |
| Immunity, Humoral | 1 | 2021 | 4849 | 0.08 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.08 | Why? |
| Kenya | 2 | 2019 | 887 | 0.07 | Why? |
| Viruses | 1 | 2019 | 2238 | 0.07 | Why? |
| Influenza A Virus, H1N1 Subtype | 1 | 2019 | 2984 | 0.07 | Why? |
| Immunization, Passive | 1 | 2020 | 10067 | 0.07 | Why? |
| Humans | 26 | 2021 | 930598 | 0.07 | Why? |
| Nucleocapsid Proteins | 3 | 2021 | 3120 | 0.06 | Why? |
| Phylogeny | 5 | 2020 | 13341 | 0.06 | Why? |
| Specimen Handling | 1 | 2021 | 6190 | 0.06 | Why? |
| Recombination, Genetic | 2 | 2020 | 1265 | 0.06 | Why? |
| Viral Proteins | 1 | 2020 | 7370 | 0.06 | Why? |
| Dogs | 2 | 2019 | 2529 | 0.06 | Why? |
| Time Factors | 2 | 2021 | 31397 | 0.05 | Why? |
| Disease Models, Animal | 1 | 2018 | 10998 | 0.05 | Why? |
| Immunoprecipitation | 1 | 2020 | 300 | 0.05 | Why? |
| Spike Glycoprotein, Coronavirus | 5 | 2021 | 37182 | 0.05 | Why? |
| Maternal Age | 1 | 2020 | 244 | 0.05 | Why? |
| Live Birth | 1 | 2020 | 200 | 0.05 | Why? |
| Viral Vaccines | 1 | 2020 | 7560 | 0.05 | Why? |
| Pregnancy Trimester, Second | 1 | 2020 | 314 | 0.05 | Why? |
| Virus Shedding | 3 | 2020 | 5834 | 0.05 | Why? |
| Peptidyl-Dipeptidase A | 1 | 2020 | 9659 | 0.05 | Why? |
| Marburgvirus | 1 | 2019 | 71 | 0.05 | Why? |
| Pregnancy Trimester, First | 1 | 2020 | 366 | 0.05 | Why? |
| Jejunum | 1 | 2018 | 82 | 0.04 | Why? |
| Umbilical Cord | 1 | 2020 | 358 | 0.04 | Why? |
| Transduction, Genetic | 1 | 2019 | 273 | 0.04 | Why? |
| Nucleic Acid Conformation | 1 | 2021 | 621 | 0.04 | Why? |
| Influenza, Human | 2 | 2019 | 10779 | 0.04 | Why? |
| Madin Darby Canine Kidney Cells | 1 | 2019 | 640 | 0.04 | Why? |
| Fetal Blood | 1 | 2020 | 573 | 0.04 | Why? |
| Protein Domains | 2 | 2020 | 6563 | 0.04 | Why? |
| Chemokine CXCL10 | 1 | 2020 | 565 | 0.04 | Why? |
| DNA Methylation | 1 | 2021 | 688 | 0.04 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.04 | Why? |
| Microcephaly | 1 | 2018 | 181 | 0.04 | Why? |
| Sequence Deletion | 1 | 2020 | 674 | 0.04 | Why? |
| Immune Tolerance | 1 | 2021 | 608 | 0.04 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.04 | Why? |
| Vietnam | 1 | 2021 | 1665 | 0.04 | Why? |
| Virus Replication | 3 | 2020 | 14331 | 0.04 | Why? |
| T-Lymphocytes, Regulatory | 1 | 2021 | 698 | 0.04 | Why? |
| Mice | 3 | 2019 | 21357 | 0.03 | Why? |
| Abortion, Spontaneous | 1 | 2020 | 776 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2020 | 11559 | 0.03 | Why? |
| Biodiversity | 1 | 2018 | 546 | 0.03 | Why? |
| Geography | 1 | 2020 | 1801 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2020 | 27595 | 0.03 | Why? |
| Glycoproteins | 1 | 2019 | 615 | 0.03 | Why? |
| Antibodies | 1 | 2020 | 846 | 0.03 | Why? |
| Interleukin-1beta | 1 | 2019 | 992 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Female | 8 | 2021 | 380317 | 0.03 | Why? |
| Ferrets | 1 | 2019 | 1201 | 0.03 | Why? |
| Respiratory Therapy | 1 | 2020 | 918 | 0.03 | Why? |
| Protein Interaction Domains and Motifs | 1 | 2020 | 2134 | 0.03 | Why? |
| Kinetics | 1 | 2020 | 3238 | 0.03 | Why? |
| Nose | 1 | 2018 | 1093 | 0.03 | Why? |
| Inflammasomes | 1 | 2019 | 710 | 0.03 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.03 | Why? |
| Administration, Oral | 1 | 2019 | 2340 | 0.03 | Why? |
| Ebolavirus | 1 | 2019 | 834 | 0.03 | Why? |
| Spatio-Temporal Analysis | 1 | 2018 | 1182 | 0.03 | Why? |
| Milk, Human | 1 | 2020 | 956 | 0.03 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.03 | Why? |
| Seroconversion | 1 | 2021 | 2515 | 0.03 | Why? |
| Cricetinae | 1 | 2019 | 3344 | 0.03 | Why? |
| Adult | 7 | 2021 | 244371 | 0.03 | Why? |
| Viral Tropism | 1 | 2019 | 1329 | 0.03 | Why? |
| Drug Combinations | 1 | 2020 | 3852 | 0.03 | Why? |
| Phosphoproteins | 1 | 2020 | 4346 | 0.03 | Why? |
| Placenta | 1 | 2020 | 1531 | 0.03 | Why? |
| Antiviral Agents | 2 | 2020 | 41703 | 0.02 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.02 | Why? |
| Epithelial Cells | 1 | 2020 | 3508 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2021 | 3444 | 0.02 | Why? |
| Male | 7 | 2021 | 367725 | 0.02 | Why? |
| Transcriptome | 1 | 2020 | 3466 | 0.02 | Why? |
| Evolution, Molecular | 1 | 2021 | 3691 | 0.02 | Why? |
| HEK293 Cells | 1 | 2020 | 8394 | 0.02 | Why? |
| Influenza A virus | 1 | 2019 | 2234 | 0.02 | Why? |
| Oxygen Inhalation Therapy | 1 | 2020 | 3629 | 0.02 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2021 | 4545 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Genetic Variation | 1 | 2020 | 3919 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Lopinavir | 1 | 2020 | 4308 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.02 | Why? |
| Ritonavir | 1 | 2020 | 4212 | 0.02 | Why? |
| Guillain-Barre Syndrome | 1 | 2018 | 1495 | 0.02 | Why? |
| Immunoglobulin M | 1 | 2021 | 9091 | 0.02 | Why? |
| Infectious Disease Transmission, Vertical | 1 | 2020 | 5164 | 0.02 | Why? |
| Cell Line | 1 | 2019 | 12040 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2018 | 10017 | 0.02 | Why? |
| Severity of Illness Index | 2 | 2020 | 48226 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2021 | 7218 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Antibodies, Neutralizing | 2 | 2018 | 25288 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Adolescent | 2 | 2021 | 86841 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2020 | 11041 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Virus Internalization | 1 | 2019 | 7921 | 0.01 | Why? |
| Aged | 3 | 2021 | 215776 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2020 | 6817 | 0.01 | Why? |
| Incidence | 1 | 2020 | 25622 | 0.01 | Why? |
| Pregnancy | 1 | 2020 | 23879 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2020 | 9044 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Cohort Studies | 1 | 2020 | 36005 | 0.01 | Why? |
| Prevalence | 1 | 2018 | 25773 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| China | 1 | 2018 | 50654 | 0.01 | Why? |
Anderson's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(175)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(227)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_